These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26869556)

  • 1. Australia commits funds to curb hepatitis C epidemic.
    McCall C
    Lancet; 2016 Jan; 387(10017):419. PubMed ID: 26869556
    [No Abstract]   [Full Text] [Related]  

  • 2. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 3. Eradication of hepatitis C infection: the importance of targeting people who inject drugs.
    Hellard M; Doyle JS; Sacks-Davis R; Thompson AJ; McBryde E
    Hepatology; 2014 Feb; 59(2):366-9. PubMed ID: 23873507
    [No Abstract]   [Full Text] [Related]  

  • 4. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Law MG; Batey RG
    Med J Aust; 2003 Mar; 178(5):197-8. PubMed ID: 12603178
    [No Abstract]   [Full Text] [Related]  

  • 5. MEDICINE. Global control of hepatitis C virus.
    Cox AL
    Science; 2015 Aug; 349(6250):790-1. PubMed ID: 26293940
    [No Abstract]   [Full Text] [Related]  

  • 6. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 7. Achieving hepatitis C elimination in Taiwan-Overcoming barriers by setting feasible strategies.
    Wu GH; Pwu RF; Chen SC
    J Formos Med Assoc; 2018 Dec; 117(12):1044-1045. PubMed ID: 30449458
    [No Abstract]   [Full Text] [Related]  

  • 8. Modelling the hepatitis C virus epidemic in Australia.
    Razali K; Thein HH; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M
    Drug Alcohol Depend; 2007 Dec; 91(2-3):228-35. PubMed ID: 17669601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we protect drug users from hepatitis C?
    Pollack HA
    J Policy Anal Manage; 2001 Apr; 20(2):358-64. PubMed ID: 12693416
    [No Abstract]   [Full Text] [Related]  

  • 10. Interventions for HIV and hepatitis C virus infections in recreational drug users.
    Khalsa JH; Elkashef A
    Clin Infect Dis; 2010 Jun; 50(11):1505-11. PubMed ID: 20415569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellence in viral hepatitis elimination - Lessons from Georgia.
    Averhoff F; Lazarus JV; Sergeenko D; Colombo M; Gamkrelidze A; Tsertsvadze T; Butsashvili M; Metreveli D; Sharvadze L; Hellard M; Gnes S; Gabunia T; Nasrullah M
    J Hepatol; 2019 Oct; 71(4):645-647. PubMed ID: 31356831
    [No Abstract]   [Full Text] [Related]  

  • 12. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
    Takács IG; Demetrovics Z
    Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug users need more choices at addiction treatment facilities.
    Alaei A; Alaei K
    BMJ; 2013 Mar; 346():f1520. PubMed ID: 23525866
    [No Abstract]   [Full Text] [Related]  

  • 14. Eliminating hepatitis C.
    Burki T
    Lancet Infect Dis; 2019 Mar; 19(3):246-247. PubMed ID: 30833063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiology of hepatitis C and human immunodeficiency virus infections among injecting drug users in Hungary--what's next?].
    Gyarmathy VA; Rácz J
    Orv Hetil; 2010 Mar; 151(10):365-71. PubMed ID: 20178967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C: cost of eradication ].
    Nau JY
    Rev Med Suisse; 2014 Jan; 10(415):306-7. PubMed ID: 24624702
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
    Sullivan LG
    Med J Aust; 1999 Aug; 171(3):165-6. PubMed ID: 10474613
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C: only a step away from elimination?
    Lancet; 2015 Mar; 385(9973):1045. PubMed ID: 25797543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.